CXCL1 and metastatic colorectal cancer: CXCL1, is known to promote recruitment and activation of neutrophils [38], premetastatic niche formation [39], tumour invasive potential [40] and tumorigenicity in metastatic colorectal cancer patients [41], and therefore, not surprisingly, serves as a biomarker for poor prognosis.